share_log

Virpax Pharmaceuticals | 8-K: Current report

Virpax Pharmaceuticals | 8-K: Current report

Virpax製藥 | 8-K:重大事件
美股sec公告 ·  07/26 16:34
Moomoo AI 已提取核心訊息
Virpax Pharmaceuticals, Inc., a Delaware-incorporated company, has announced the full prepayment of its senior secured promissory note on July 25, 2024. The note, which was issued to an investor on July 5, 2024, had a maturity date of December 31, 2025, and was secured by a lien on all of the company's assets. The total payment made by Virpax Pharmaceuticals included both the principal and accrued interest, amounting to approximately $2,525,000. The note carried an interest rate of 18% per annum. This financial move was disclosed in a Form 8-K report filed with the United States Securities and Exchange Commission. The company, listed on The Nasdaq Capital Market under the trading symbol VRPX, is also classified as an emerging growth company.
Virpax Pharmaceuticals, Inc., a Delaware-incorporated company, has announced the full prepayment of its senior secured promissory note on July 25, 2024. The note, which was issued to an investor on July 5, 2024, had a maturity date of December 31, 2025, and was secured by a lien on all of the company's assets. The total payment made by Virpax Pharmaceuticals included both the principal and accrued interest, amounting to approximately $2,525,000. The note carried an interest rate of 18% per annum. This financial move was disclosed in a Form 8-K report filed with the United States Securities and Exchange Commission. The company, listed on The Nasdaq Capital Market under the trading symbol VRPX, is also classified as an emerging growth company.
Virpax Pharmaceuticals公司是一家註冊於特拉華州的公司,在2024年7月25日宣佈已全額償付其於2024年7月5日向投資者發行的高級擔保本票,該本票的到期日爲2025年12月31日,並以公司的所有資產作抵押。Virpax Pharmaceuticals所支付的總金額包括本金和應計利息,共計約252.5萬美元。該本票的年利率爲18%。該項財務舉措已在提交給美國證券交易委員會的8-K表格中披露。該公司以交易代號VRPX在納斯達克資本市場上市,也歸類爲新興成長型公司。
Virpax Pharmaceuticals公司是一家註冊於特拉華州的公司,在2024年7月25日宣佈已全額償付其於2024年7月5日向投資者發行的高級擔保本票,該本票的到期日爲2025年12月31日,並以公司的所有資產作抵押。Virpax Pharmaceuticals所支付的總金額包括本金和應計利息,共計約252.5萬美元。該本票的年利率爲18%。該項財務舉措已在提交給美國證券交易委員會的8-K表格中披露。該公司以交易代號VRPX在納斯達克資本市場上市,也歸類爲新興成長型公司。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息